161 related articles for article (PubMed ID: 34923953)
1. LncRNA ADAMTS9-AS1 knockdown suppresses cell proliferation and migration in glioma through downregulating Wnt/β-catenin signaling pathway.
Zhou C; Zhao H; Wang S; Dong C; Yang F; Zhang J
Bosn J Basic Med Sci; 2022 Jun; 22(3):395-402. PubMed ID: 34923953
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS9-AS1 Long Non‑coding RNA Sponges miR‑128 and miR-150 to Regulate Ras/MAPK Signaling Pathway in Glioma.
Javanmard AR; Jahanbakhshi A; Nemati H; Mowla SJ; Soltani BM
Cell Mol Neurobiol; 2023 Jul; 43(5):2309-2322. PubMed ID: 36449154
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer.
Chen W; Tu Q; Yu L; Xu Y; Yu G; Jia B; Cheng Y; Wang Y
Hum Cell; 2020 Oct; 33(4):1133-1141. PubMed ID: 32918700
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
Gai SY; Yuan ZH
Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker.
Li N; Li J; Mi Q; Xie Y; Li P; Wang L; Binang H; Wang Q; Wang Y; Chen Y; Wang Y; Mao H; Du L; Wang C
J Cell Mol Med; 2020 Oct; 24(19):11318-11329. PubMed ID: 32889785
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer.
Li Z; Yue G; Zhang T; Wu J; Tian X
Histol Histopathol; 2021 Oct; 36(10):1063-1072. PubMed ID: 34085704
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/β-catenin signaling pathways.
He L; Yang H; Zhu XL; Zhang Y; Lv K
Brain Res Bull; 2021 Nov; 176():112-120. PubMed ID: 34474120
[TBL] [Abstract][Full Text] [Related]
11. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
Mei JC; Yan G; Mei SQ
Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
Wang F; Zhu W; Yang R; Xie W; Wang D
Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
17. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
[TBL] [Abstract][Full Text] [Related]
18. Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway.
Xiang Z; Lv Q; Chen X; Zhu X; Liu S; Li D; Peng X
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32735016
[TBL] [Abstract][Full Text] [Related]
19. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma.
Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q
Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
